Carcinoma: all 6,718 studies

Page 19 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01836029Phase 2Results posted
• Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaCompletedNCT01835626Phase 2Results posted
• Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01835223Phase 1/2Results posted
• Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney CancerCompletedNCT01835158Phase 2Results posted
• Surgery and Heated Chemotherapy for Adrenocortical CarcinomaCompletedNCT01833832Phase 2Results posted
• BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal CarcinomaCompletedNCT01830621Phase 3Results posted
• First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract CarcinomaCompletedNCT01828034Phase 1/2Results posted
• Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of RecurrenceTerminatedNCT01824823Phase 2Results posted
• Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the SkinTerminatedNCT01823679Phase 2Results posted
• Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)TerminatedNCT01821963Phase 3Results posted
• Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyCompletedNCT01819233Not applicableResults posted
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell CarcinomasCompletedNCT01815840Phase 2Results posted
• Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerCompletedNCT01811212Phase 2Results posted
• Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell CarcinomaTerminatedNCT01808950Phase 1/2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell CarcinomaTerminatedNCT01806064Phase 1/2Results posted
• Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by SurgeryCompletedNCT01802320Phase 2Results posted
• Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular CarcinomaCompletedNCT01798134Not applicableResults posted
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• Arsenic Trioxide in Treating Patients With Basal Cell CarcinomaCompletedNCT01791894Phase 1/2Results posted
• Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder CancerCompletedNCT01780545Phase 2Results posted
• Carfilzomib in Refractory Renal Cell Carcinoma (RCC)CompletedNCT01775930Phase 2Results posted
• Study of Regorafenib After Sorafenib in Patients With Hepatocellular CarcinomaCompletedNCT01774344Phase 3Results posted
• A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian CancerTerminatedNCT01773889Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney CancerCompletedNCT01767636Phase 2Results posted
• Sirolimus in Kidney Transplant Patients With Squamous Cell Skin CarcinomaTerminatedNCT01764607Phase 2Results posted
• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular CarcinomaCompletedNCT01761266Phase 3Results posted
• Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking HistoryCompletedNCT01758731Phase 1Results posted
• Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior TherapyCompletedNCT01755767Phase 3Results posted
• A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and EffectiveCompletedNCT01754987Phase 1/2Results posted
• Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryTerminatedNCT01754519Phase 2Results posted
• Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal CancerCompletedNCT01748942Not applicableResults posted
• A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric CancersCompletedNCT01743469Phase 2Results posted
• Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.TerminatedNCT01737827Phase 2Results posted
• Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expressionTerminatedNCT01732107Phase 2Results posted
• A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal CancerTerminatedNCT01729923Phase 2Results posted
• Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell CarcinomaTerminatedNCT01727336Phase 2Results posted
• Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney CancerCompletedNCT01727089Phase 2Results posted
• Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01720173Phase 2Results posted
• Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01716715Phase 2Results posted
• Imaging Studies of Kidney Cancer Using 18F-VM4-037TerminatedNCT01712685Phase 2Results posted
• Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck CancerCompletedNCT01711541Phase 1/2Results posted
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsCompletedNCT01709435Phase 1Results posted
• Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic SubtypesCompletedNCT01700049Phase 2Results posted
• A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive TractCompletedNCT01697800Phase 2Results posted
• Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by SurgeryCompletedNCT01696955Phase 2Results posted
• Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical CancerCompletedNCT01693783Phase 2Results posted
• Cabozantinib for Advanced Urothelial CancerCompletedNCT01688999Phase 2Results posted
• Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by SurgeryCompletedNCT01688973Phase 2Results posted
• Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01687673Phase 2Results posted
• Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric CancerTerminatedNCT01683864Phase 2/3Results posted
• Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyTerminatedNCT01682031Phase 2Results posted
• A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCCTerminatedNCT01673386Phase 2Results posted
• Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)CompletedNCT01668784Phase 3Results posted
• Advanced Image Guidance Utilized in Liver SurgeryCompletedNCT01666145Not applicableResults posted
• Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney CancerCompletedNCT01664182Phase 2Results posted
• Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaCompletedNCT01661179Phase 1/2Results posted
• Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyCompletedNCT01658943Phase 2Results posted
• Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular CarcinomaCompletedNCT01655693Phase 3Results posted
• NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell CarcinomaTerminatedNCT01649180Phase 2Results posted
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)CompletedNCT01642186Phase 2Results posted
• Dalantercept in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01642082Phase 2Results posted
• Hepatic Xenetix-CT PerfusionCompletedNCT01639703Phase 4Results posted
• Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01639352Phase 2Results posted
• Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerCompletedNCT01631552Phase 1/2Results posted
• Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)CompletedNCT01631331Early Phase 1Results posted
• Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerCompletedNCT01622868Phase 2Results posted
• Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal CarcinomaCompletedNCT01621880Phase 2Results posted
• Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst CarcinomaCompletedNCT01604772Phase 2Results posted
• A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT01602315Phase 1/2Results posted
• Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the VulvaStatus unknownNCT01595061Phase 2Results posted
• Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular CarcinomaCompletedNCT01594125Phase 1Results posted
• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01592721Phase 1/2Results posted
• A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other CancersCompletedNCT01587703Phase 1Results posted
• Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib TosylateTerminatedNCT01582009Phase 1/2Results posted
• Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the AnusCompletedNCT01581840Phase 1/2Results posted
• Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01576172Phase 2Results posted
• Tivantinib in Treating Patients With Recurrent or Metastatic Breast CancerCompletedNCT01575522Phase 2Results posted
• 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA TrialCompletedNCT01563354Phase 2Results posted
• Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic CarcinomaCompletedNCT01558661Phase 2Results posted
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver CancerCompletedNCT01556490Not applicableResults posted
• Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell CarcinomasCompletedNCT01556009Phase 2Results posted
• Buparlisib in Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT01551030Phase 2Results posted
• Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)CompletedNCT01550367Phase 1/2Results posted
• Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell CarcinomaTerminatedNCT01545817Phase 2Results posted
• Vismodegib for Treatment of Basal Cell CarcinomaCompletedNCT01543581Phase 2Results posted
• Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT01540565Phase 2Results posted
• Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436CompletedNCT01534897Not applicableResults posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened InhibitorsCompletedNCT01529450Not applicableResults posted
• First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial CarcinomaCompletedNCT01524991Phase 2Results posted
• Study of Dovitinib (TKI258) in Adenoid Cystic CarcinomaCompletedNCT01524692Phase 2Results posted
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based ChemotherapyCompletedNCT01523587Phase 3Results posted
• Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal CarcinomaCompletedNCT01519869Phase 2Results posted
• Phase II Study of Alternating Sunitinib and TemsirolimusCompletedNCT01517243Phase 2Results posted
• Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or PazopanibCompletedNCT01514448Phase 4Results posted
• Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerCompletedNCT01505868Phase 1/2Results posted
• Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesTerminatedNCT01505166Phase 2Results posted
• Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01503229Phase 2Results posted

← Carcinoma overview